GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,974,000 | +3.5% | 91,359 | +3.6% | 0.05% | +14.6% |
| Q1 2022 | $3,840,000 | -6.7% | 88,201 | -5.5% | 0.04% | 0.0% |
| Q4 2021 | $4,114,000 | +17.5% | 93,350 | +1.8% | 0.04% | +10.8% |
| Q3 2021 | $3,502,000 | +14.1% | 91,692 | +19.0% | 0.04% | +23.3% |
| Q2 2021 | $3,068,000 | +11.1% | 77,083 | -0.5% | 0.03% | -3.2% |
| Q1 2021 | $2,762,000 | +270.7% | 77,478 | +282.1% | 0.03% | +244.4% |
| Q4 2020 | $745,000 | +13.7% | 20,279 | +16.8% | 0.01% | 0.0% |
| Q3 2020 | $655,000 | -10.4% | 17,363 | -3.1% | 0.01% | -18.2% |
| Q2 2020 | $731,000 | -51.6% | 17,916 | -55.0% | 0.01% | -47.6% |
| Q1 2020 | $1,509,000 | +95.2% | 39,853 | +141.9% | 0.02% | +90.9% |
| Q4 2019 | $773,000 | +11.1% | 16,472 | +0.8% | 0.01% | +10.0% |
| Q3 2019 | $696,000 | +11.2% | 16,339 | +4.3% | 0.01% | +11.1% |
| Q2 2019 | $626,000 | -9.1% | 15,671 | -4.9% | 0.01% | -18.2% |
| Q1 2019 | $689,000 | +9.7% | 16,480 | +0.1% | 0.01% | 0.0% |
| Q4 2018 | $628,000 | +4.3% | 16,457 | +9.6% | 0.01% | +10.0% |
| Q3 2018 | $602,000 | -3.7% | 15,016 | -3.0% | 0.01% | 0.0% |
| Q2 2018 | $625,000 | -1.4% | 15,488 | -4.3% | 0.01% | -9.1% |
| Q1 2018 | $634,000 | +1.3% | 16,181 | -8.1% | 0.01% | 0.0% |
| Q4 2017 | $626,000 | -45.4% | 17,609 | -37.6% | 0.01% | -50.0% |
| Q3 2017 | $1,146,000 | -8.1% | 28,242 | -2.4% | 0.02% | -12.0% |
| Q2 2017 | $1,247,000 | -2.2% | 28,932 | -4.5% | 0.02% | -7.4% |
| Q1 2017 | $1,275,000 | -6.7% | 30,284 | -14.7% | 0.03% | -12.9% |
| Q4 2016 | $1,366,000 | -36.3% | 35,500 | -28.6% | 0.03% | -38.0% |
| Q3 2016 | $2,144,000 | +0.8% | 49,729 | +1.2% | 0.05% | +2.0% |
| Q2 2016 | $2,128,000 | -3.5% | 49,163 | -9.5% | 0.05% | -9.3% |
| Q1 2016 | $2,206,000 | -0.1% | 54,318 | -0.8% | 0.05% | -1.8% |
| Q4 2015 | $2,209,000 | +5.5% | 54,733 | +0.2% | 0.06% | 0.0% |
| Q3 2015 | $2,093,000 | -6.9% | 54,620 | +0.7% | 0.06% | -5.2% |
| Q2 2015 | $2,249,000 | -7.2% | 54,258 | +3.3% | 0.06% | -7.9% |
| Q1 2015 | $2,423,000 | +19.1% | 52,535 | +10.3% | 0.06% | +16.7% |
| Q4 2014 | $2,034,000 | +7.6% | 47,638 | +16.0% | 0.05% | +1.9% |
| Q3 2014 | $1,891,000 | -8.3% | 41,058 | +6.6% | 0.05% | -8.6% |
| Q2 2014 | $2,063,000 | +6.3% | 38,528 | +6.2% | 0.06% | +1.8% |
| Q1 2014 | $1,940,000 | +2.6% | 36,271 | +1.9% | 0.06% | +3.6% |
| Q4 2013 | $1,891,000 | +1.3% | 35,585 | -4.3% | 0.06% | -5.2% |
| Q3 2013 | $1,867,000 | -0.3% | 37,198 | -0.8% | 0.06% | +1.8% |
| Q2 2013 | $1,872,000 | – | 37,497 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |